Healthcare Triangle, Inc.

As of November 23, 2021, Healthcare Triangle, Inc. is considered overvalued and risky due to negative financial metrics and a year-to-date return of -98.94%, significantly underperforming compared to the S&P 500's 12.22% gain.

As of November 23, 2021, Healthcare Triangle, Inc. is considered a risky investment due to its negative financial metrics and significant underperformance, with a year-to-date return of -96.86%, compared to peers like MMTec and NetSol Technologies.

As of April 5, 2024, Healthcare Triangle, Inc. has a bearish technical outlook, with weak strength indicated by bearish moving averages and KST signals, despite mildly bullish MACD readings.

Healthcare Triangle, Inc. is a micro-cap company in the Computers - Software & Consulting industry, reporting net sales of $4 million and a net loss of $2 million as of March 2025. It has a market cap of $9.03 million and key metrics indicating financial challenges, including a negative return on equity and no dividend yield.

As of Jun 18, Healthcare Triangle, Inc. has a market capitalization of 9.03 million, with net sales of 11.28 million and a net profit of -5.81 million over the last four quarters. The company reported shareholder's funds of -5.11 million and total assets of 1.96 million as of Dec 24.